Poly(2‐ethyl‐2‐oxazoline) (POx) as Poly(ethylene glycol) (PEG)‐Lipid Substitute for Lipid Nanoparticle Formulations
Small · 2025-04 · 21 (16)
DOI: 10.1002/smll.202411354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 19.03.2025. Verfasst von Caroline T Holick und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University, Jena, Germany, Humboldtstraße 10, 07743, Jena, Germany. Hauptthemen laut MEDLINE: Polyethylene Glycols, Nanoparticles, Lipids, Polyamines. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thüringer Aufbaubank, BMWK, Bundesministerium für Wirtschaft und Klimaschutz.
Abstract (Originalsprache)
Polyoxazolines have long been considered as promising alternatives to poly(ethylene glycol) (PEG) due to their comparable properties, in particular regarding their stealth effect toward the immune system. Lipid nanoparticles (LNPs), as utilized, e.g., in the COVID‐19 vaccines, contain PEG‐lipids. However, alternatives are required because of the “PEG dilemma” recognized by an increase in anti‐PEG antibodies in the human population. In this study, poly(2‐ethyl‐2‐oxazoline) (PEtOx)‐based lipids with different degrees of polymerization are synthesized and subsequently used to formulate mRNA‐loaded LNPs. The effect of polymer chain length on the size, immunoreaction, and transfection efficiency is investigated in detail. In addition, in‐depth transfection studies are performed using super‐resolution microscopy (SRM) to investigate the uptake mechanism of PEtOx‐based LNPs in comparison to PEG‐LNPs. These combined approaches are utilized to identify the best performing LNP, being superior to the commercial PEG‐lipid used in the Comirnaty formulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University, Jena, Germany, Humboldtstraße 10, 07743, Jena, Germany.
- Jena Center for Soft Matter (JCSM), Friedrich Schiller University, Jena, Germany, Philosophenweg 7, 07743, Jena, Germany.
- Helmholtz Institute for Polymers in Energy Applications Jena (HIPOLE Jena), Lessingstraße 12-14, 07743, Jena, Germany.
- Institute of Applied Optics and Biophysics (IAOB), Friedrich Schiller University, Jena, Germany, Helmholtzweg 4, 07743, Jena, Germany.
- Helmholtz-Zentrum Berlin für Materialien und Energie GmbH (HZB), Hahn-Meitner-Platz 1, 14109, Berlin, Germany.
ORCID-Profile: Anja Traeger, Stephanie Schubert, Ulrich S Schubert
Förderung
- Thüringer Aufbaubank
- BMWK
- Bundesministerium für Wirtschaft und Klimaschutz
- BASE-Lipid
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Holick, C. T., Klein, T., Mehnert, C., Adermann, F., Anufriev, I., Streiber, M., Harder, L., Traeger, A., Hoeppener, S., Franke, C., Nischang, I., Schubert, S., & Schubert, U. S. (2025). Poly(2‐ethyl‐2‐oxazoline) (POx) as Poly(ethylene glycol) (PEG)‐Lipid Substitute for Lipid Nanoparticle Formulations. Small, 21(16). https://doi.org/10.1002/smll.202411354
Vancouver
Holick CT, Klein T, Mehnert C, Adermann F, Anufriev I, Streiber M, et al. Poly(2‐ethyl‐2‐oxazoline) (POx) as Poly(ethylene glycol) (PEG)‐Lipid Substitute for Lipid Nanoparticle Formulations. Small. 2025;21(16). doi:10.1002/smll.202411354
BibTeX
@article{Holick2025,
author = {Holick, Caroline T and Klein, Tobias and Mehnert, Charlotte and Adermann, Franziska and Anufriev, Ilya and Streiber, Michael and Harder, Lukas and Traeger, Anja and Hoeppener, Stephanie and Franke, Christian and Nischang, Ivo and Schubert, Stephanie and Schubert, Ulrich S},
title = {Poly(2‐ethyl‐2‐oxazoline) (POx) as Poly(ethylene glycol) (PEG)‐Lipid Substitute for Lipid Nanoparticle Formulations},
journal = {Small},
year = {2025},
volume = {21},
number = {16},
doi = {10.1002/smll.202411354}
}
EUVIMED